Research

Call Closed

HRCI/HRB Joint Funding Scheme 2024

 

Introduction

The Rotunda Foundation is pleased to announce that it has launched a call for research applications to take part in the HRCI/HRB Joint Funding Scheme 2024.

The Rotunda Foundation is a member of Health Research Charities Ireland (HRCI- formerly Medical Research Charities Group), which was founded in 1998 with the aim of supporting charities in Ireland to increase both the quality and quantity of healthcare research being done in Ireland. The HRCI represents the joint interests of charities within its membership that specialise in restoring health through medical research, diagnosis and treatment and, where possible, the prevention of disease.

The HRCI-HRB Joint Funding Scheme aims to fund researchers and research teams to conduct internationally competitive and innovative research in areas of strategic relevance to each charity.

The Rotunda Foundation will prioritise research applications that are consistent with our research objectives: To promote and foster the carrying out of high-quality, internationally relevant research, including new procedures and encourage the investigation of the action and effects of various treatment procedures that will be of benefit to women’s health and social care in relation to the delivery of services provided by the Rotunda Hospital.

Funding

The HRCI/HRB Joint Funding Scheme will provide funding for projects up to a maximum of €300,000 per award for projects that have a duration of between 12 – 36 months. (The Rotunda Foundation will provide a budget of up to a maximum of €150,000.) The earliest start date of the grant will be 1st October 2024.

How To Apply

Opening Date of Expression of Interest: 18th September 2023

  • Applicants wishing to express their intention to submit an application should send an email to: contact@rotundafoundation.ie with the following information:-
  1. A brief outline of their application
  2. Proposed Project Title
  3. Funding Cost of Project
  4. 5 key words
  5. Which strategic area(s) is the proposed project addressing
  6. Name of the Host Institution
  7. The name and contact details of the Lead Applicant.

Closing Date for Expression of Interest: 30th September 2023

  • The Foundation will subsequently invite these submissions to make to a full application with the downloaded HRCI/HRB Joint Funding Scheme documents, collated and sent to contact@rotundafoundation.ie

Closing Date for Full Applications: 5pm, Tuesday 31st October 2023

Downloads

B1 HRCI HRB 2024 Part-B1 Application Form

C1 HRCI HRB 2024 Part-C1 Collaboration Agreement

C2 HRCI HRB 2024 Part-C2 Infrastructure Agreement

D1 HRCI HRB 2024 Part-D1 Lead Applicant Signature Page

D2 HRCI-HRB 2024 Part-D2 PI Host Institution Signature Page

HRCI-HRB-JFS-2024 Guidance Notes for Applicants final

Our Key Objective:

To promote and foster the carrying out of high quality research, including new procedures, to increase knowledge and information of the various services provided by the Rotunda Hospital.

The Rotunda Foundation has been committed to supporting the Rotunda’s Clinical & Research Programme since its establishment in 1973 and provides vital seed funding for researchers to start their projects.

The Foundation believes that the provision of the best possible outcomes for mothers and babies requires continuous practice improvement and that research helps to identify new and improved treatment options for the future.

The Foundation supports the Rotunda’s participation in research and quality improvement projects that are essential to providing a platform for high quality and safe patient care.

Donations to this fund, helps the Foundation to achieve its goal and furthers research and development at the Rotunda hospital.

Research Funded by The Foundation

ON GOING

GRACE

HYPATIA

PERIMETER

SMARTPHONE APP

FOR SURVEILLANCE OF
GESTATIONAL DIABETES

RECIPE

HOTPOT

NEUROIMAGING

WITH DETAILED CTG
AND PLACENTAL ANALYSIS

PATENT DUCTUS ARTERIOSUS TREATMENT

EPIDURAL RELATED MATERNAL FEVER

DEBUNKING THE MYTHS

CCHD

Phase 2: Intrapartum CTG and Partogram Characteristics

HPAA

COMPLETED

Medication Safety

IND-HOME Trial

SafeBoosC-III

NSHIE

Immune Signatures in Vaginal Mucous

FilmArray PCR Platform

ERPC

ROTUNDA COMMUNICATIONS PROGRAMME

SUMMIT

Neonatal Noise Exposure

Intrapartum CTG and Partogram Characteristics

Neurocognitive Sequelae of Hypoxic Ischaemic Encephalopathy

PEAR

MAMMI Study

HANDLE

Maternal Group B Streptococcus Screening

GPPP

NBAC

MICE Trial

Characterisation of Proinflammatory Extracellular Vesicles

CAPE Study

keyboard_arrow_up